文献速递眼底病与葡萄膜炎神经眼科

梅毒性葡萄膜炎的预后因素

Prognostic Factors in Syphilitic Uveitis.
PubMed 文献 · Ophthalmology · 2017-08-02

这项回顾性多中心分析纳入66例患者共95只眼,评估梅毒性葡萄膜炎治疗后1周和1个月的炎症活动度。1个月时65%的患眼恢复,末次随访时85%恢复;多因素分析显示治疗1周时的临床改善可预测1个月恢复,而球周注射地塞米松和甲泼尼龙冲击治疗对预后有负面影响。

要点

  • 治疗1周时的临床改善是梅毒性葡萄膜炎1个月眼科恢复的最强预测因素(cRR 3.5,95%CI 2.3-3.8,P=0.001)。
  • 球周注射地塞米松(cRR 0.05,95%CI 0.02-0.6,P=0.01)和甲泼尼龙冲击治疗对患眼预后有负面影响。
  • 1个月时65%的患眼恢复,末次随访时85%的患眼恢复。

核心结论

  • 早期改善是梅毒性葡萄膜炎眼科恢复的最强预测因素。

研究设计与样本

  • 回顾性多中心分析,纳入接受治疗的梅毒性葡萄膜炎患者66例共95只眼,平均(标准差)年龄49(12.5)岁,其中31例(47%)为人类免疫缺陷病毒(HIV)阳性。

主要发现

  • 全葡萄膜炎和后葡萄膜炎是最常见的表现。
  • HIV阳性患者的炎症指标更高。
  • 1个月时65%的患眼恢复,末次随访时85%的患眼恢复。
  • 多因素分析中,调整初始最佳矫正视力和抗微生物治疗方案后,治疗1周时的临床改善可预测1个月时的恢复(校正风险比[cRR] 3.5,95%CI 2.3-3.8,P=0.001)。
  • 球周注射地塞米松(cRR 0.05,95%CI 0.02-0.6,P=0.01)和甲泼尼龙冲击治疗对患眼预后有负面影响。

关键数值与推荐

  • 改善定义为前房和玻璃体混浊炎症水平均较基线下降至少2级,且脉络膜视网膜病灶缩小。
  • 恢复定义为1个月时所有解剖结构的炎症消退。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To identify predictors of treatment success in syphilitic uveitis (SU). DESIGN: Retrospective multicentric analysis of patients treated for SU. PARTICIPANTS: A total of 95 eyes (66 patients, mean [standard deviation] aged 49 [12.5] years, 31 [47%] of whom were human immunodeficiency virus [HIV]+) were analyzed. METHODS: Activity of SU was assessed at 1 week and 1 month after treatment onset, and at last follow-up. Improvement was defined by a ≥2-step decrease of both anterior chamber and vitreous haze inflammation levels, and by the size reduction in chorioretinal lesions. MAIN OUTCOME MEASURES: Recovery was defined as the resolution of inflammation in all anatomic structures at 1 month. RESULTS: Panuveitis and posterior uveitis were the most frequent findings. Inflammatory parameters were higher in HIV+ patients. Recovery was reported in 65% and 85% of eyes at 1 month and at last follow-up, respectively. In multivariate analysis, after adjusting for initial best-corrected visual acuity and the antimicrobial treatment regimen, clinical improvement at 1 week (corrected risk ratios [cRR], 3.5 [2.3-3.8]; P = 0.001) was predictive of recovery at 1 month, whereas the use of periocular dexamethasone injections (cRR, 0.05 [0.02-0.6]; P = 0.01) and methylprednisolone pulses negatively affected the outcomes of eyes. CONCLUSIONS: Early improvement is the strongest predictor of ophthalmological recovery in SU.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Hoogewoud F, Frumholtz L, Loubet P, et al. Prognostic Factors in Syphilitic Uveitis. Ophthalmology. 2017. PMID: 28779905. doi:10.1016/j.ophtha.2017.06.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。